|

TJ033721 (givastomig), durvalumab, chemotherapy Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • I-Mab Biopharma US Limited1

Indications

  • Gastroesophageal Junction Carcinoma1
  • Biliary Tract Cancer (BTC)1
  • PDAC - Pancreatic Ductal Adenocarcinoma1
  • Advanced Cancer1
  • Esophageal Adenocarcinoma1

Orange, California1 trial

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Stern Center for Cancer Clinical Trials and Research

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.